top of page
News, Events and Updates
Search
Anavex Comments on President Obama's National Plan to Fight Alzheimer's Disease
May 30, 2012
Anavex to Present Corporate Update at BIO CEO & Investor Conference
Feb 14, 2012
Anavex Successfully Completes a Phase 1 Clinical Trial for ANAVEX 2-73
Nov 14, 2011
Anavex Appoints Dr. George Tidmarsh as Executive Director
Oct 12, 2011
Anavex Announces Director Resignation
Sep 16, 2011
Anavex to Present Data on ANAVEX 2-73, Lead Compound for Alzheimer's Disease
Sep 15, 2011
Anavex Presents Data on Neuroprotective Evidence for ANAVEX 2-73, Lead Compound for AD
Jul 26, 2011
Anavex Presents Data on Potential Dual Utility of ANAVEX 2-73 in Both Amyloid and Tau Pathology
Jul 25, 2011
Preclinical Development of New Tetrahydrofuran Derivatives Targeting the Sigma-1 Chaperone Protein
Jul 16, 2011
The novel tetrahydrofuran derivative ANAVEX2-73 attenuated GSK-3β activation and Tau...
Jul 16, 2011
Anavex to Present at Alzheimer's Association International Conference on Alzheimer's Disease
Jul 15, 2011
42
43
44
45
46
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
